Cited by 111Advanced Glycation End Products researchAdipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Serum advanced glycation end products (AGEs) are associated with insulin resistance

Tan, Kathryn C. B., Shiu, Sammy W. M., Wong, Ying, Tam, Xystus·2011·Diabetes/Metabolism Research and Reviews

Abstract

Background: In addition to the important role of advanced glycation end products (AGEs) in the pathogenesis of diabetic vascular complications, recent data suggest that advanced glycation end products can also impair insulin action in vitro. We have investigated whether circulating advanced glycation end products are associated with insulin resistance in human subjects independent of metabolic parameters. Methods: Two hundred and seven healthy non‐obese non‐diabetic subjects (97 male, 110 female) were recruited from the community. Serum levels of advanced glycation end products, adiponectin, malondialdehyde and high sensitivity C‐reactive protein were assayed. Insulin resistance was determined by the homeostasis model assessment index (HOMA‐IR). Results: Male subjects had significantly higher body mass index, waist circumference and lower adiponectin level than female subjects and were more insulin resistant. Serum advanced glycation end products (3.67 ± 1.15 unit/mL versus 3.23 ± 1.15, p < 0.05) and malondialdehyde levels (p < 0.05) were also higher in male than in female subjects. Serum advanced glycation end products correlated with HOMA‐IR in both male (r = 0.32, p = 0.004) and female subjects (r = 0.28, p = 0.003). Serum adiponectin inversely correlated with HOMA‐IR in female (r = − 0.38, p < 0.001) but not in male subjects. On multiple regression analysis, serum AGEs remained an independent determinant of HOMA‐IR even after adjusting for age, gender, body mass index, waist, smoking, adiponectin and markers of oxidative stress and inflammation. Conclusions: Formation and accumulation of advanced glycation end products progress during normal ageing. We have demonstrated that the circulating level of advanced glycation end products is associated with insulin resistance even in non‐obese, non‐diabetic subjects independent of adiponectin. Copyright © 2011 John Wiley & Sons, Ltd.

Integrity signals

Registry

Crossref · 10.1002/dmrr.1188

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tan, K. C. B., Shiu, S. W. M., Wong, Y., & Tam, X.
Affiliations
Queen Mary Hospital (CN)
Corresponding author
Tan, Kathryn C. B.
Venue
Diabetes/Metabolism Research and Reviews
Publisher
Wiley
Published
2011-07
Volume
27
Issue
5
Pages
488-492
ISSN
  • 1520-7552 (ISSN-L)
  • 1520-7560
OpenAlex
W1970415033
Cited by
111
References
28
Citations by year
2026: 2 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 3 · 2020: 8 · 2019: 10 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 12 · 2014: 8 · 2013: 7 · 2012: 4
FWCI
4.24
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes/Metabolism Research and Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
advanced glycation end products, insulin resistance, adiponectin, malondialdehyde, C-reactive protein, sex differences, aging, oxidative stress, inflammation, HOMA-IR
MeSH terms
Adult, C-Reactive Protein, Female, Humans, Insulin Resistance, Male, Middle Aged, Glycation End Products, Advanced, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review